Nurix Therapeutics, Inc.NRIXNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-285.67M
↓ 117% below average
Average (7y)
$-131.56M
Historical baseline
Range
High:$-9.74M
Low:$-285.67M
CAGR
+62.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-285.67M | -34.1% |
| 2024 | $-213.03M | -37.4% |
| 2023 | $-155.06M | +15.7% |
| 2022 | $-183.87M | -56.0% |
| 2021 | $-117.89M | -81.4% |
| 2020 | $-64.98M | -192.2% |
| 2019 | $-22.24M | -128.3% |
| 2018 | $-9.74M | - |